Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jan 13, 2025 · Filed Jan 15, 2025
A Castle Biosciences director sold $914 of Castle Biosciences shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$914
Shares × reported transaction price
on the day of results (Jan 13, 2025), 45 days before results of Feb 27, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.6% | +3.1% | +2.6% |
| 30 days | +6.5% | +3.4% | +3.1% |
| 90 days | −15.3% | −11.2% | −4.1% |
| 180 days | −24.8% | +5.2% | −29.9% |
| 365 days | +59.5% | +16.9% | +42.6% |
Past results only. Not a forecast.
Fund moves
4 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Fund moves
4 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 13, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Daniel Bradbury (Director) sold ~$141K of Castle Biosciences
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
